ABL1 and acute lymphoblastic leukemia: IKZF1 deletion has a poor prognostic effect and is more frequent (60–90%) in B-ALL with BCR-ABL1 or high risk non-BCR-ABL1 ALL (~ 30%) than other B-ALL subtype, as shown in our results2, 11, 22, 23.